Suven Life Sciences board to consider annual accounts

06 Aug 2012 Evaluate
Suven Life Sciences has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to consider and approve the audited annual accounts for the year ended March 31, 2012 and to recommend dividend for the financial year ended March 31,2012, if any.

Further, the board will announce book closure for the purpose of AGM and will consider and take on record the un-audited financial results for the first quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Suven Life Sciences Share Price

170.95 2.50 (1.48%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×